Dimethyl Itaconate As A Novel Anti-Inflammatory Agent Targeting Tnf-Α-Driven Nf-Κb Activation In Epithelial Cell Models. The Review of Diabetic Studies , [S. l.], p. 1–21, 2025. DOI: 10.1900/q356v768. Disponível em: https://www.diabeticstudies.org/index.php/RDS/article/view/493. Acesso em: 24 sep. 2025.